Cargando…

Chitotriosidase as a biomarker of cerebral adrenoleukodystrophy

BACKGROUND: Adrenoleukodystrophy (ALD) is an X-linked peroxisomal disorder characterized by the abnormal beta-oxidation of very long chain fatty acids (VLCFA). In 35-40% of children with ALD, an acute inflammatory process occurs in the central nervous system (CNS) leading to demyelination that is ra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Orchard, Paul J, Lund, Troy, Miller, Wes, Rothman, Steven M, Raymond, Gerald, Nascene, David, Basso, Lisa, Cloyd, James, Tolar, Jakub
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236018/ https://www.ncbi.nlm.nih.gov/pubmed/22014002 http://dx.doi.org/10.1186/1742-2094-8-144

Ejemplares similares

Cerebrospinal Fluid Matrix Metalloproteinases Are Elevated in Cerebral Adrenoleukodystrophy and Correlate with MRI Severity and Neurologic Dysfunction
por: Thibert, Kathryn A., et al.
Publicado: (2012)

Association between APOE4 and biomarkers in cerebral adrenoleukodystrophy
por: Orchard, Paul J., et al.
Publicado: (2019)

Elevated Cerebral Spinal Fluid Cytokine Levels in Boys with Cerebral Adrenoleukodystrophy Correlates with MRI Severity
por: Lund, Troy C., et al.
Publicado: (2012)

Post‐transplant adaptive function in childhood cerebral adrenoleukodystrophy
por: Pierpont, Elizabeth I., et al.
Publicado: (2018)

Failure of intrathecal allogeneic mesenchymal stem cells to halt progressive demyelination in two boys with cerebral adrenoleukodystrophy
por: Gupta, Ashish, et al.
Publicado: (2020)

Neurocognitive benchmarks following transplant for emerging cerebral adrenoleukodystrophy
por: Pierpont, Elizabeth I., et al.
Publicado: (2020)

Glycoprotein nonmetastatic melanoma protein B (GNMPB) as a novel biomarker for cerebral adrenoleukodystrophy
por: Taghizadeh, Leyla A., et al.
Publicado: (2022)

Differential outcomes for frontal versus posterior demyelination in childhood cerebral adrenoleukodystrophy
por: Gupta, Ashish O., et al.
Publicado: (2021)

Evaluation of Neurofilament Light Chain as a Biomarker of Neurodegeneration in X-Linked Childhood Cerebral Adrenoleukodystrophy
por: Wang, Hongge, et al.
Publicado: (2022)

A case series of adrenoleukodystrophy in children conceived through in vitro fertilization with an egg donor
por: Chang, Crystal, et al.
Publicado: (2022)

Cerebral Spinal Fluid levels of Cytokines are elevated in Patients with Metachromatic Leukodystrophy
por: Thibert, Kathryn A., et al.
Publicado: (2016)

Isoprostanoid Plasma Levels Are Relevant to Cerebral Adrenoleukodystrophy Disease
por: Signorini, Cinzia, et al.
Publicado: (2022)

Adrenal Insufficiency in an Adolescent Boy With Type 1 Diabetes Mellitus - the Importance of Considering X-Linked Adrenoleukodystrophy
por: Wiersma, Rebecca, et al.
Publicado: (2021)

Chitotriosidase as a biomarker for gangliosidoses
por: Kim, Sarah, et al.
Publicado: (2021)

A report on state‐wide implementation of newborn screening for X‐linked Adrenoleukodystrophy
por: Wiens, Katie, et al.
Publicado: (2019)

N-Acetylcysteine Reverses the Mitochondrial Dysfunction Induced by Very Long-Chain Fatty Acids in Murine Oligodendrocyte Model of Adrenoleukodystrophy
por: Zhou, Jie, et al.
Publicado: (2021)

Primary Adrenal Insufficiency in a Boy with Type I Diabetes: The Importance of Considering X-linked Adrenoleukodystrophy
por: Wiersma, Rebecca E, et al.
Publicado: (2022)

Childhood cerebral adrenoleukodystrophy
por: Mittal, Aliza, et al.
Publicado: (2014)

Elevated cerebral spinal fluid biomarkers in children with mucopolysaccharidosis I-H
por: Raymond, Gerald V., et al.
Publicado: (2016)

Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis
por: Bennett, David, et al.
Publicado: (2020)

Modeling and rescue of defective blood–brain barrier function of induced brain microvascular endothelial cells from childhood cerebral adrenoleukodystrophy patients
por: Lee, Catherine A. A., et al.
Publicado: (2018)

A novel mouse model of cerebral adrenoleukodystrophy highlights NLRP3 activity in lesion pathogenesis
por: Hashemi, Ezzat, et al.
Publicado: (2023)

Chitotriosidase - a putative biomarker for sporadic amyotrophic lateral sclerosis
por: Varghese, Anu Mary, et al.
Publicado: (2013)

Correction to: Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis
por: Bennett, David, et al.
Publicado: (2020)

Immunomodulatory Effects of Chitotriosidase Enzyme
por: Elmonem, Mohamed A., et al.
Publicado: (2016)

Exploratory Evaluation of Neopterin and Chitotriosidase as Potential Circulating Biomarkers for Colorectal Cancer
por: Ciocan, Andra, et al.
Publicado: (2023)

Molecular Biomarkers for Adrenoleukodystrophy: An Unmet Need
por: Honey, Madison I. J., et al.
Publicado: (2021)

International Recommendations for the Diagnosis and Management of Patients With Adrenoleukodystrophy: A Consensus-Based Approach
por: Engelen, Marc, et al.
Publicado: (2022)

The relationship between chitotriosidase activity and tuberculosis
por: CHEN, M., et al.
Publicado: (2015)

Human Chitotriosidase Is an Endo-Processive Enzyme
por: Kuusk, Silja, et al.
Publicado: (2017)

Neurofilament light chain levels in cerebrospinal fluid as a sensitive biomarker for cerebral adrenoleukodystrophy
por: Kakumoto, Toshiyuki, et al.
Publicado: (2023)

Biomarker-based risk prediction for the onset of neuroinflammation in X-linked adrenoleukodystrophy
por: Weinhofer, Isabelle, et al.
Publicado: (2023)

Variables affecting outcomes after allogeneic hematopoietic stem cell transplant for cerebral adrenoleukodystrophy
por: Chiesa, Robert, et al.
Publicado: (2022)

Chitotriosidase and Neopterin as Potential Biomarkers for the Evaluation of Complicated Cholecystitis—A Pilot Study
por: Nechita, Vlad-Ionuţ, et al.
Publicado: (2023)

Chitotriosidase is a biomarker for adult‐onset leukoencephalopathy with axonal spheroids and pigmented glia
por: Hayer, Stefanie N., et al.
Publicado: (2022)

Newborn Screening for X-Linked Adrenoleukodystrophy
por: Moser, Ann B., et al.
Publicado: (2016)

Correction to “Neurofilament light chain levels in cerebrospinal fluid as a sensitive biomarker for cerebral adrenoleukodystrophy”
Publicado: (2023)

Chitotriosidase: a marker and modulator of lung disease
por: Chang, De, et al.
Publicado: (2020)

Evaluation of Circulating Chitotriosidase Activity in Children with Obesity
por: Țaranu, Ioana, et al.
Publicado: (2022)

Newborn Screening for X-Linked Adrenoleukodystrophy: Past, Present, and Future
por: Moser, Ann B., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_856n4r6g55s51c2p6878ui1bre